One good thing that came out of the CR was TOX were not tempted to grab the xtra 14m of retail shareholder's funds and issue even more shares hence causing unnecessary dilution. The cash flow is good, margins steady and company well positioned. No surprise to see SP regain ground on a weak day re ASX. Divs should improve in FY17.